News

RepliCel Life Sciences to Present at World Stem Cell Summit 2014

10 years ago Dec 01, 2014

Over multiple sessions, Lee Buckler will present a RepliCel update, participate in session panels, and...

RepliCel Life Sciences Receives Health Canada Clearance for Clinical Trial in Patients with Chronic Achilles Tendinosis

10 years ago Nov 30, 2014

Health Canada Issues “No Objection Letter” for RepliCel’s Phase 1/2 Clinical Trial of RCT-01 VANCOUVER,...

RepliCel Announces 2014 Third Quarter Financial Results

10 years ago Nov 25, 2014

VANCOUVER, BC – November 26, 2014 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)...

November 7, 2014 – R. Lee Buckler: How RepliCel is Harnessing the Awesome Power of Cell Therapy

10 years ago Nov 06, 2014

To read the full report, click here: R. Lee Bucker on RepliCel Life SciencesRegenerative medicine...

RepliCel Submits Clinical Trial Application to Health Canada for its Chronic Achilles Tendinosis Trial

10 years ago Oct 28, 2014

Autologous cell therapy, RCT-01, to be investigated for treatment of tendinopathies refractory to other treatments...

Midas Letter Interviews CEO David Hall

10 years ago Oct 23, 2014

To listen to the full interview podcast and read the transcript click here: Midas Letter...

Japan Gives a Hug to the Cell Therapy Industry: R. Lee Buckler

10 years ago Oct 21, 2014

To read the full report click here: R. Lee Buckler on the Cell Therapy IndustryLast...

Seeking Alpha – Why RepliCel is a Promising Under-Researched Small-Cap Biotech

10 years ago Oct 09, 2014

By: Eric Chiu, Biotech, Healthcare Contributor Published October 10, 2014To read the entire article as...

RepliCel to Present Commercial and Clinical Update at BioJapan 2014 World Business Forum

10 years ago Oct 08, 2014

Japanese meetings to focus on partnering VANCOUVER, BC – October 9, 2014 – RepliCel Life...

RepliCel Life Sciences Adds Industry Specialist to Management Team

10 years ago Oct 06, 2014

Newly Appointed Vice-President of Business & Corporate Development to Drive External Initiatives VANCOUVER, BC –...

RepliCel to Present Clinical Trial Update at Stem Cell Meeting on the Mesa Partnering Forum in California

10 years ago Oct 01, 2014

VANCOUVER, BC – October 2, 2014 – RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: REPCF),...

Seeking Alpha Article – RepliCel Offers Significant Upside

10 years ago Sep 24, 2014

To view the article as it appears on Seeking Alpha, click here.Summary RepliCel is a...

RepliCel Retains Market-Making Services

10 years ago Sep 11, 2014

VANCOUVER, BC – September 12, 2014 – RepliCel Life Sciences Inc. (TSXV: RP) (OTCQB: REPCF)...

RepliCel Garners Feature on Fox Business News and the Financial Post

10 years ago Sep 08, 2014

RepliCel’s Innovative Technology Converts Your Own Cells into Products to Repair and Rejuvenate the Body...

September 9th, 2014- Featured in the Financial Post: New Technology Puts Your Own Cells to Work to Repair and Rejuvenate Your Body

10 years ago Sep 08, 2014

To read the full report click here: RepliCel’s Cutting-Edge Advancements The following has been published...

September 9th, 2014- RepliCel marches ahead with cell therapy trials

10 years ago Sep 08, 2014

New in BioWorld, the latest in RepliCel’s cell therapy trials and what they could mean...

RepliCel to Present at Rodman & Renshaw’s 16th Annual Global Investment Conference in New York

10 years ago Sep 03, 2014

VANCOUVER, BC – September 4, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP),...

RepliCel Life Sciences Joins Centre for Commercialization of Regenerative Medicine, Industry Consortium

10 years ago Sep 02, 2014

CCRM and RepliCel to Partner on Development of Cell Therapies for Tendon Repair VANCOUVER, BC...

RepliCel Announces 2014 Second Quarter Financial Results

10 years ago Aug 25, 2014

VANCOUVER, BC – August 26, 2014 – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”)(TSXV:RP)...

August 7, 2014 – Mark Landy from Summer Street Research Partners Comments on RepliCel in August’s issues of The Life Sciences Report

10 years ago Aug 06, 2014

To read the full report click here: Mark Landy on New Growth Ideas for Biotech...

by Type

by Topic

by month

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.